Regulatory role of NKT cells in the prevention of type 1 diabetes;Rôle régulateur des lymphocytes NKT dans la prévention du diabète de type 1

Medecine/Sciences

Volumn 29, Issue 8-9, 2013, Pages 722-728

  Ghazarian, Liana ^a,b,c   Simoni, Yannick ^a,b,c   Pingris, Karine ^a,c   Beaudoin, Lucie ^a,b,c   Lehuen, Agnès ^a,b,c,d  

^a INSTITUT COCHIN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Universite de Paris Diderot   (France)

^d HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ALPHA-GALACTOSYLCERAMIDE; GALACTOSYLCERAMIDE; INTERLEUKIN 10; INTERLEUKIN 4;

ANIMAL; ANTIGEN PRESENTATION; ARTICLE; DENDRITIC CELL; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NATURAL KILLER CELL; PHYSIOLOGY; VIRUS INFECTION;

ANIMALS; ANTIGEN PRESENTATION; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; GALACTOSYLCERAMIDES; HOMEOSTASIS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; INTERLEUKIN-4; KILLER CELLS, NATURAL; MICE; VIRUS DISEASES;

EID: 84884632032     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/2013298010     Document Type: Article

References (33)

1. Lehuen A, Diana J, Zaccone P, Cooke A. Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol 2010; 10: 501-13.
2. Diana J, Simoni Y, Furio L, et al. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med 2013; 19: 65-73.
3. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007; 25: 297-336.
4. Simoni Y, Diana J, Ghazarian L, et al. Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality? Clin Exp Immunol 2013; 171: 8-19.
5. Gombert JM, Herbelin A, Tancrede-Bohin E, et al. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur J Immunol 1996; 26: 2989-98.
6. Hammond KJ, Pellicci DG, Poulton LD, et al. CD1d-restricted NKT cells: an interstrain comparison. J Immunol 2001; 167: 1164-73.
7. Lehuen A, Lantz O, Beaudoin L, et al. Overexpression of natural killer T cells protects Valpha14-Jalpha281 transgenic nonobese diabetic mice against diabetes. J Exp Med 1998; 188: 1831-9.
8. Falcone M, Facciotti F, Ghidoli N, et al. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice. J Immunol 2004; 172: 5908-16.
9. Wang B, Geng YB, Wang CR. CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J Exp Med 2001; 194: 313-20.
10. Shi FD, Flodstrom M, Balasa B, et al. Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse. Proc Natl Acad Sci USA 2001; 98: 6777-82.
11. Rapoport MJ, Jaramillo A, Zipris D, et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 1993; 178: 87-99.
12. Laloux V, Beaudoin L, Jeske D, et al. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen. J Immunol 2001; 166: 3749-56.
13. Hammond KJ, Poulton LD, Palmisano LJ, et al. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med 1998; 187: 1047-56.
14. Chen YG, Choisy-Rossi CM, Holl TM, et al. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. J Immunol 2005; 174: 1196-204.
15. Beaudoin L, Laloux V, Novak J, et al. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells. Immunity 2002; 17: 725-36.
16. Naumov YN, Bahjat KS, Gausling R, et al. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc Natl Acad Sci USA 2001; 98: 13838-43.
17. Novak J, Beaudoin L, Park S. Prevention of type 1 diabetes by invariant NKT cells is independent of peripheral CD1d expression. J Immunol 2007; 178:1332-40.
18. Novak J, Beaudoin L, Griseri T, Lehuen A. Inhibition of T cell differentiation into effectors by NKT cells requires cell contacts. J Immunol 2005; 174: 1954-61.
19. Michel ML, Keller AC, Paget C, et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 2007; 204: 995-1001.
20. Simoni Y, Gautron AS, Beaudoin L, et al. NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes. Eur J Immunol 2011; 41: 3574-85.
21. Wilson SB, Kent SC, Patton KT, et al. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 1998; 391: 177-81.
22. Kis J, Engelmann P, Farkas K, et al. Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus. J Leukoc Biol 2007; 81: 654-62.
23. Kent SC, Chen Y, Clemmings SM, et al. Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells. J Immunol 2005; 175: 4458-64.
24. Diana J, Brezar V, Beaudoin L, et al. Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay. J Exp Med 2011; 208: 729-45.
25. Oldstone MB. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science 1988; 239: 500-2.
26. Diana J, Griseri T, Lagaye S, et al. NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner. Immunity 2009; 30: 289-99.
27. Sharif S, Arreaza GA, Zucker P, et al. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 2001; 7: 1057-62.
28. Wang J, Cho S, Ueno A, et al. Ligand-dependent induction of noninflammatory dendritic cells by anergic invariant NKT cells minimizes autoimmune inflammation. J Immunol 2008; 181: 2438-45.
29. Blumenfeld HJ, Tohn R, Haeryfar SM, et al. Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice. Clin Exp Immunol 2011; 166: 121-33.
30. Ghazarian L, Diana J, Simoni Y, et al. Prevention or acceleration of type 1 diabetes by viruses. Cell Mol Life Sci 2013; 70: 239-55.
31. Motohashi S, Ishikawa A, Ishikawa E, et al. A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent nonsmall cell lung cancer. Clin Cancer Res 2006; 12: 6079-86.
32. Brennan PJ, Tatituri RV, Brigl M, et al. Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat Immunol 2011; 12: 1202-11.
33. Hegde S, Lockridge JL, Becker YA, et al. Human NKT cells direct the differentiation of myeloid APCs that regulate T cell responses via expression of programmed cell death ligands. J Autoimmun 2011; 37: 28-8.